Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
HKD 0.64
(1.59%)
HKD 0.64
(1.59%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -54.01 Million CNY | 97.23% |
| 2022 | -1.95 Billion CNY | -568.47% |
| 2021 | 416.5 Million CNY | -12.01% |
| 2020 | 473.38 Million CNY | 117.47% |
| 2019 | -2.7 Billion CNY | -267.25% |
| 2018 | 1.61 Billion CNY | 11.8% |
| 2017 | 1.44 Billion CNY | -15.18% |
| 2016 | 1.7 Billion CNY | -17.17% |
| 2015 | 2.06 Billion CNY | 23.4% |
| 2014 | 1.67 Billion CNY | 28.26% |
| 2013 | 1.3 Billion CNY | 44.07% |
| 2012 | 904.4 Million CNY | 9.75% |
| 2011 | 824.04 Million CNY | 57.84% |
| 2010 | 522.06 Million CNY | 59.99% |
| 2009 | 326.31 Million CNY | 37.65% |
| 2008 | 237.05 Million CNY | 32.24% |
| 2007 | 179.26 Million CNY | 98.19% |
| 2006 | 90.45 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -33.42 Million CNY | 0.0% |
| 2023 FY | -54.01 Million CNY | 97.23% |
| 2023 Q2 | -49.64 Million CNY | 0.0% |
| 2023 Q4 | -4.37 Million CNY | 0.0% |
| 2022 FY | -1.95 Billion CNY | -568.47% |
| 2022 Q2 | 40.37 Million CNY | 0.0% |
| 2021 FY | 416.5 Million CNY | -12.01% |
| 2021 Q2 | 611.42 Million CNY | 0.0% |
| 2020 Q2 | 174.42 Million CNY | 0.0% |
| 2020 Q4 | 333.87 Million CNY | 0.0% |
| 2020 FY | 473.38 Million CNY | 117.47% |
| 2019 Q4 | -711.39 Million CNY | 0.0% |
| 2019 Q2 | -1.99 Billion CNY | 0.0% |
| 2019 FY | -2.7 Billion CNY | -267.25% |
| 2018 FY | 1.61 Billion CNY | 11.8% |
| 2018 Q4 | 854.28 Million CNY | 0.0% |
| 2018 Q2 | 765.67 Million CNY | 0.0% |
| 2017 Q2 | 842.45 Million CNY | 0.0% |
| 2017 Q4 | 606.47 Million CNY | 0.0% |
| 2017 FY | 1.44 Billion CNY | -15.18% |
| 2016 Q2 | 735.96 Million CNY | 0.0% |
| 2016 FY | 1.7 Billion CNY | -17.17% |
| 2016 Q4 | 972.27 Million CNY | 0.0% |
| 2015 Q4 | 610.82 Million CNY | 0.0% |
| 2015 FY | 2.06 Billion CNY | 23.4% |
| 2015 Q2 | 1.45 Billion CNY | 0.0% |
| 2014 FY | 1.67 Billion CNY | 28.26% |
| 2014 Q4 | 847.89 Million CNY | 0.0% |
| 2014 Q2 | 823.38 Million CNY | 0.0% |
| 2013 FY | 1.3 Billion CNY | 44.07% |
| 2013 Q4 | 667.34 Million CNY | 103.76% |
| 2013 Q3 | 327.52 Million CNY | -46.96% |
| 2013 Q2 | 617.53 Million CNY | 88.55% |
| 2013 Q1 | 327.52 Million CNY | 0.0% |
| 2012 Q4 | 327.52 Million CNY | 42.16% |
| 2012 FY | 904.4 Million CNY | 9.75% |
| 2012 Q2 | 230.38 Million CNY | 0.0% |
| 2012 Q1 | 230.38 Million CNY | 0.0% |
| 2012 Q3 | 230.38 Million CNY | 0.0% |
| 2011 Q4 | 230.38 Million CNY | 15.19% |
| 2011 Q3 | 200 Million CNY | 0.0% |
| 2011 Q2 | 200 Million CNY | 0.0% |
| 2011 Q1 | 200 Million CNY | 0.0% |
| 2011 FY | 824.04 Million CNY | 57.84% |
| 2010 Q4 | 200 Million CNY | 57.83% |
| 2010 FY | 522.06 Million CNY | 59.99% |
| 2010 Q1 | 126.72 Million CNY | 0.0% |
| 2010 Q2 | 126.72 Million CNY | 0.0% |
| 2010 Q3 | 126.72 Million CNY | 0.0% |
| 2009 Q4 | 126.72 Million CNY | 61.61% |
| 2009 FY | 326.31 Million CNY | 37.65% |
| 2009 Q3 | 78.41 Million CNY | 0.0% |
| 2009 Q2 | 78.41 Million CNY | 0.0% |
| 2009 Q1 | 78.41 Million CNY | 0.0% |
| 2008 Q3 | 58.36 Million CNY | 0.0% |
| 2008 Q1 | 58.36 Million CNY | 0.0% |
| 2008 FY | 237.05 Million CNY | 32.24% |
| 2008 Q2 | 58.36 Million CNY | 0.0% |
| 2008 Q4 | 78.41 Million CNY | 34.36% |
| 2007 Q2 | 44.7 Million CNY | 0.0% |
| 2007 Q1 | 44.7 Million CNY | 0.0% |
| 2007 Q3 | 44.7 Million CNY | 0.0% |
| 2007 FY | 179.26 Million CNY | 98.19% |
| 2007 Q4 | 58.36 Million CNY | 30.54% |
| 2006 FY | 90.45 Million CNY | 0.0% |
| 2006 Q1 | 22.54 Million CNY | 0.0% |
| 2006 Q3 | 22.54 Million CNY | 0.0% |
| 2006 Q4 | 44.7 Million CNY | 98.31% |
| 2006 Q2 | 22.54 Million CNY | 0.0% |
| 2005 Q4 | 22.54 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | 151.426% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | 102.873% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 66.85% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | -251.765% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | -2.489% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | 423.494% |
| Essex Bio-Technology Limited | 275.25 Million HKD | 119.624% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | -87.279% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 49.079% |
| SSY Group Limited | 1.31 Billion HKD | 104.096% |
| JBM (Healthcare) Limited | 130.46 Million HKD | 141.404% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | 120.234% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 101.401% |